Forst, Thomas <br/><br/>
Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control.  [electronic resource] 

 -  Experimental diabetes research  2012 
 - 635472 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1687-5303 
<br/><br/><label>Standard No.: </label>10.1155/2012/635472  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose<br/>Body Weight--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diabetic Angiopathies--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--pharmacology<br/>Endothelium, Vascular--drug effects<br/>Glucagon-Like Peptide 1--agonists<br/>Humans<br/>Hypoglycemic Agents--pharmacology